title: Clinical markers of immunodeficiency and mechanism of immune reconstitution inflammatory syndrome and highly active antiretroviral therapy on HIV: workshop 3A.
abstract: Antiretroviral therapy (ART) has improved survival and changed the disease pattern of HIV infection. However, ART may cause serious side effects, such as metabolic and cardiovascular complications. In addition, immune reconstitution inflammatory syndrome (IRIS) is being increasingly reported in relation to ART. The article presents the consensus of a workshop around 4 key issues: (1) the differences in the response of adults and children to highly active antiretroviral therapy, (2) the mechanism of the new HIV entry inhibitors and its effect on oral markers, (3) the pathogenesis of IRIS and the contradictory findings of the possible oral lesions related with IRIS, (4) and the benefits and barriers associated with using ART in the developing and developed world. The consensus of the workshop was that there is a need for future studies on the oral manifestations of HIV in individuals treated with new ARTs-especially, children. IRIS was considered a promising field for future research; as such, workshop attendees recommended formulating an IRIS-oral lesions case definition and following strict criteria for its diagnosis.
authors: Department of Health Sciences. Universidad Autónoma Metropolitana-Xochimilco, México City, Mexico.
authors: V
authors: V
authors: Ramirez-Amador
authors: W
authors: W
authors: Nittayananta
authors: M
authors: M
authors: Magalhães
authors: S R
authors: SR
authors: Flint
authors: B S
authors: BS
authors: Peters
authors: A R
authors: AR
authors: Tappuni
mesh_terms: D000328:Adult; D000367:Age Factors; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects*; D015415:Biomarkers; D065100:CCR5 Receptor Antagonists; D002648:Child; D003906:Developing Countries; D017144:Focus Groups; D023581:HIV Fusion Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000209:etiology* / Q000473:pathology
chemical_list: D015415:Biomarkers; D065100:CCR5 Receptor Antagonists; D023581:HIV Fusion Inhibitors